Use of bubropion in elderly patients

Manel Sánchez-Pérez, Carlos Roncero, Facund Fora, Verónica Gálvez-Ortiz, Narcis Cardoner-Álvarez, Jose M. Crespo-Blanco, Victor Navarro-Odriozola, Gemma Gareía-Parés, Josefina Pérez-Bianco

Research output: Contribution to journalReview articleResearchpeer-review


Mood state disorders are, together with anxiety, the most common psychiatric disorder in the elderly. They are generally associated to multiple conditions that are frequent in elderly age, such as pain, somatic disease or cognitive deterioration and to psychosocial factors (loneliness, impoverishment, discapacity or mourning). Depression in the elderly has an important impact on the quality of life and general health in this age and noticeably casts a shadow over the functional prognosis or survival related with the concomitant medical diseases. It also contributes, in a large degree, to the stress of the caregiver. In the daily clinical practice, depression in the elderly is underdetected and undertreated in spite of the effectiveness of the treatments available. In the antidepressive drug treatment in the elderly, it is important to achieve its effectiveness without jeopardizing safety. The experience in the use of bupropion as an antidepressant in elderly patients is presented.
Original languageEnglish
Pages (from-to)14-16
JournalActas Espanolas de Psiquiatria
Issue numberSUPPL. 2
Publication statusPublished - 1 Oct 2011


Dive into the research topics of 'Use of bubropion in elderly patients'. Together they form a unique fingerprint.

Cite this